Alexia Bertuzzi - Concepedia

Author

Alexia Bertuzzi

Also Known As

A Bertuzzi, A F Bertuzzi, A. Bertuzzi, A. F. Bertuzzi, A.F. Bertuzzi, Alberto Bertuzzi, Alexia Bertuzzi, Alexia F. Bertuzzi, Alexia Francesca Bertuzzi, Andrea Marrari

175

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Humanitas University Istituti di Ricovero e Cura a Carattere Scientifico Fondazione IRCCS Istituto Nazionale dei Tumori IRCCS Humanitas Research Hospital Fondazione Humanitas per la Ricerca

About

Alexia Bertuzzi is an author at Humanitas University specializing in medicine, oncology, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	594
2	Public Health	4	4	81
3	Health Sciences	3	3	63
4	Nursing	2	2	35
5	Biomedical Engineering	1	1	16

Alexia Bertuzzi

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy Corrado Lodigiani, G. Iapichino, Luca Carenzo, Thrombosis Research	2020	2.1K
Phase II Study of Imatinib in Advanced Chordoma Silvia Stacchiotti, Alessandra Longhi, Virginia Ferraresi, Journal of Clinical Oncology	2012	264
Retroperitoneal Sarcoma: Is It Time to Change the Surgical Policy? Chiara Mussi, Piergiuseppe Colombo, Alexia Bertuzzi, Annals of Surgical Oncology Surgical OncologyRetroperitoneal SarcomaSurgical PathologySurgeryGeneral Surgery	2011	90
High-Dose Chemotherapy in Poor-Prognosis Adult Small Round-Cell Tumors: Clinical and Molecular Results From a Prospective Study Alexia Bertuzzi, Luca Castagna, Andrea Nozza, Journal of Clinical Oncology	2002	71
Prognostic Factors for Survival inMetastatic Renal Cell Carcinoma:Retrospective Analysis from109 Consecutive Patients Giovanni Citterio, Alexia Bertuzzi, Moreno Tresoldi, European Urology	1997	70
Time-Dependent COVID-19 Mortality in Patients With Cancer Mark Bower, Ramón Salazar, Alexia Bertuzzi, JAMA Oncology	2021	70
Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014) Jean‐Yves Blay, Alexia Bertuzzi, Stefan Bielack, Data Archiving and Networked Services (DANS) Surgical OncologyGastrointestinal OncologyMedicineSurgical PathologyGastroenterology	2015	59
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy Armando Santoro, Alessandro Comandone, Umberto Basso, Annals of Oncology Anthracycline-based TherapySurgical OncologyMalignant DiseaseMedicinePathology	2012	54
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients Elena Azzolini, Chiara Pozzi, Luca Germagnoli, Life Science Alliance	2022	53
The “old drug” dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas Paolo Andrea Zucali, Alexia Bertuzzi, Héctor Soto Parrà, Investigational New Drugs Second/third Line ChemotherapyMedicinePharmacologyPathologyPharmacotherapy	2007	48

Page 1